Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.
Portsmouth CCG Primary Care Rebate Scheme Policy can be found here.
Please note that Portsmouth CCG will only consider signing up to a rebate that has been reviewed by PrescQIPP.
Current schemes that Portsmouth CCG has signed up to as of November 2020:
|Effective end date
|Xgeva (Denosumab 70mg/mL)
|1st November 2024
|28th February 2024
|February 2021 (auto-renewal)
|Longtec (Oxycodone MR)
|Flynn Pharma Ltd